Status:
NOT_YET_RECRUITING
Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The incidence of nasopharyngeal carcinomas (NPCs) is highly unbalanced around the globe, primarily concentrated in East and Southeast Asia.There is no well-conducted, larger randomized controlled tria...
Detailed Description
It is planned to recruit 250 primary NPC patients from Fujian Cancer Hospital's Oncology Departments during an 18-month period, after completing the chemoradiotherapy for NPC. You will participate in ...
Eligibility Criteria
Inclusion
- Able to provide informed consent;
- Have completed radiotherapy treatment for loco-regional nasopharyngeal carcinoma without clinical sign of distance metastatis;
- Aged 18 years and above;
- Expected survival ≥6 months;
- Read, understand Chinese characters and speak Mandarin.
Exclusion
- Previous history of other malignancies, mental illness or cognitive impairment (MMSE score \< 27 points);
- Unstable medical or psychiatric conditions
- Inability to communicate effectively in mandarin
- Pregnant women or lactating women.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06572293
Start Date
November 1 2024
End Date
December 1 2030
Last Update
October 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.